A Skagit Valley Chorale rehearsal early last year became a deadly COVID-19 superspreader event. Now, the group is figuring out how to come back together and reforge the bonds of a community choir.
Scientists around the world are working on a way to inject vaccines painlessly. The trick is to make the needles so small. they don't interact with the nerve endings that signal pain.
African nations had been counting on Serum Institute of India for nearly all their COVID vaccines. Now the company says it won't be sending any more for months. And African officials are scrambling.
While natural infection does seem to provide some immunity, studies suggest that it is short term. Vaccination, on the other hand, provides more robust immunity.
President Biden said the U.S. is distributing them not to curry favor with allies, but to end the pandemic everywhere. And he's doing it through COVAX.
The New York Yankees have reported eight "breakthrough" cases among vaccinated staff and a player. Scientists say the outbreak is in line with what's already known about the Johnson & Johnson vaccine.
Children's immunizations dropped dramatically during the pandemic, and health officials are eager to get kids caught back up on their routine shots before they return to school.
A coronavirus variant is spreading quickly in India, causing a massive surge in cases. Scientists are rushing to see if vaccines will be effective against this variant. So far, the news is hopeful.
It's inspiring when a spirit of generosity goes global. But to fight this pandemic, well-off nations must do their part. That's why we think Biden's stand on vaccine patents is a vital step.
The agreement provides a significant boost to the European Union's goal of getting 70% of adults vaccinated. Currently, around a quarter of the bloc's population is vaccinated.
Surgeon General Vivek Murthy says that while confidence in COVID-19 vaccines has risen, there's more work to do in convincing people, especially in rural communities, to get the shots.
In the U.S., more than 1 out of 5 residents is fully vaccinated against COVID-19. But elsewhere in the world, vaccination rates are much lower. Some poor nations have yet to receive a single dose.
Dr. Scott Gottlieb doesn't expect enough demand for the vaccine much beyond 160 million Americans. But he says there may eventually be enough immunity to curb the spread of the coronavirus.
One of the hottest areas of research right now: studies to determine how well current vaccines work against emerging coronavirus "variants of concern."
